2020 ASCO Virtual Direct™ Highlights
2020 ASCO Ovarian Q & A: Does Cediranib Have a Future In Ovarian Cancer? What Are the Preferred PARP Inhibitors and Is There Concern of AML/MDS?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Gerardo Colon-Otero
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Gerardo Colon-Otero
Login to view comments.
Click here to Login
